Shaanxi Kanghui Pharm Co Ltd (603139) - Total Liabilities
Based on the latest financial reports, Shaanxi Kanghui Pharm Co Ltd (603139) has total liabilities worth CN¥1.12 Billion CNY (≈ $164.48 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Shaanxi Kanghui Pharm Co Ltd (603139) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Shaanxi Kanghui Pharm Co Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Shaanxi Kanghui Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Shaanxi Kanghui Pharm Co Ltd asset portfolio.
Shaanxi Kanghui Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shaanxi Kanghui Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bohai Ferry Co Ltd
SHG:603167
|
China | CN¥628.06 Million |
|
Consultatio SA
BA:CTIO
|
Argentina | AR$632.44 Billion |
|
Nuveen Dynamic Municipal Opportunities Fund
NYSE:NDMO
|
USA | $289.43 Million |
|
Australian Agricultural Company Ltd
AU:AAC
|
Australia | AU$930.75 Million |
|
Universal Cables Limited
NSE:UNIVCABLES
|
India | Rs24.32 Billion |
|
Saimo Electric Co Ltd
SHE:300466
|
China | CN¥387.13 Million |
|
WIA Gold Ltd
AU:WIA
|
Australia | AU$1.23 Million |
|
Suzhou Alton Electrical & Mechanical Industry Co. Ltd.
SHE:301187
|
China | CN¥2.75 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Shaanxi Kanghui Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Shaanxi Kanghui Pharm Co Ltd net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shaanxi Kanghui Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shaanxi Kanghui Pharm Co Ltd (2012–2025)
The table below shows the annual total liabilities of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.25 Billion ≈ $182.25 Million |
+26.96% |
| 2024-12-31 | CN¥980.94 Million ≈ $143.54 Million |
-4.93% |
| 2023-12-31 | CN¥1.03 Billion ≈ $150.99 Million |
+29.66% |
| 2022-12-31 | CN¥795.75 Million ≈ $116.44 Million |
+6.78% |
| 2021-12-31 | CN¥745.20 Million ≈ $109.05 Million |
+212.75% |
| 2020-12-31 | CN¥238.27 Million ≈ $34.87 Million |
+109.28% |
| 2019-12-31 | CN¥113.85 Million ≈ $16.66 Million |
-13.01% |
| 2018-12-31 | CN¥130.88 Million ≈ $19.15 Million |
+9.34% |
| 2017-12-31 | CN¥119.70 Million ≈ $17.52 Million |
-9.43% |
| 2016-12-31 | CN¥132.16 Million ≈ $19.34 Million |
+9.38% |
| 2015-12-31 | CN¥120.82 Million ≈ $17.68 Million |
+7.61% |
| 2014-12-31 | CN¥112.27 Million ≈ $16.43 Million |
-4.34% |
| 2013-12-31 | CN¥117.37 Million ≈ $17.17 Million |
+11.44% |
| 2012-12-31 | CN¥105.31 Million ≈ $15.41 Million |
-- |
About Shaanxi Kanghui Pharm Co Ltd
Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates in China. It is involved in the research, development, production, and sale of traditional Chinese medicine preparations; research and development of prepared slices of Chinese medicinal herbs and pharmaceutical intermediates; and pharmaceutical distribution of biolo… Read more